Fiche publication
Date publication
novembre 2020
Journal
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Auteurs
Membres identifiés du Cancéropôle Est :
Dr POUTHIER Fabienne
Tous les auteurs :
Coffe C, Pouthier F, Barisien C, Slimane M, Sheytanova A
Lien Pubmed
Résumé
The management of hyperleukocytosis or thrombocytosis by therapeutic cytapheresis in the early 21 st century is far from codified (universal). Therapeutic cytapheresis have been proposed to achieve more rapid cytoreduction in peripheral blood than old universal support in order to quickly prevent potential complications. But, there are no randomized studies demonstrating the superiority of cytapheresis over other treatments alone. In this short review, based on our own experience (since 1980), we will give the indications and the role of cytapheresis procedures and we will try to answer the questions: when is therapeutic cytapheresis appropriate and do they still have a place in 2020, especially as a medical emergency?
Mots clés
Cytapheresis, Hyperleukocytosis, Leukapheresis, Thrombapheresis, Thrombocytosis
Référence
Transfus Apher Sci. 2020 Nov 2;:102997
